Back to top
more

Cronos Group (CRON)

(Delayed Data from NSDQ)

$2.59 USD

2.59
2,348,676

+0.09 (3.60%)

Updated Apr 26, 2024 03:59 PM ET

After-Market: $2.60 +0.01 (0.39%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

F Value A Growth F Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 36% (91 out of 252)

Industry: Medical - Drugs

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Balance Sheet

Research for CRON

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

 

Fiscal Year End for Cronos Group Inc falls in the month of December.

All items in Millions except Per Share data.

12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Assets          
Cash & Equivalents 862 878 1,005 1,290 1,506
Receivables 30 29 28 19 12
Notes Receivable 6 9 5 7 5
Inventories 31 38 33 44 38
Other Current Assets 5 7 9 12 9
Total Current Assets 933 960 1,080 1,372 1,570
Net Property & Equipment 59 61 74 188 162
Investments & Advances 55 90 135 20 20
Other Non-Current Assets 69 72 81 87 45
Deferred Charges 0 0 0 0 0
Intangibles 22 28 19 249 287
Deposits & Other Assets 0 0 0 0 0
Total Assets 1,140 1,213 1,398 1,926 2,090
Liabilities & Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Notes Payable 0 0 26 0 0
Accounts Payable 12 11 11 42 35
Current Portion Long-Term Debt 0 0 0 0 0
Current Portion Capital Leases 1 1 3 1 0
Accrued Expenses 28 22 0 0 0
Income Taxes Payable 0 33 0 0 0
Other Current Liabilities 0 0 14 163 297
Total Current Liabilities 41 68 54 207 333
Mortgages 0 0 0 0 0
Deferred Taxes/Income 0 0 0 0 0
Convertible Debt 0 0 0 0 0
Long-Term Debt 0 0 0 0 0
Non-Current Capital Leases 2 3 7 8 7
Other Non-Current Liabilities 1 1 2 2 2
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 44 72 63 218 341
Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Preferred Stock 0 0 0 0 0
Common Stock (Par) 614 611 596 569 561
Capital Surplus 48 43 32 35 23
Retained Earnings 417 491 659 1,065 1,138
Other Equity 17 -4 47 40 27
Treasury Stock 0 0 0 0 0
Total Shareholder's Equity 1,096 1,141 1,334 1,708 1,749
Total Liabilities & Shareholder's Equity 1,140 1,213 1,398 1,926 2,090
Total Common Equity 1,096 1,141 1,334 1,708 1,749
Shares Outstanding 381.30 380.40 374.90 360.20 348.80
Book Value Per Share 2.87 3.00 3.56 4.74 5.01

Fiscal Year End for Cronos Group Inc falls in the month of December.

All items in Millions except Per Share data.

3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Assets          
Cash & Equivalents -99,999 862 840 841 836
Receivables NA 30 32 27 22
Notes Receivable NA 6 5 5 6
Inventories NA 31 36 45 44
Other Current Assets NA 5 6 7 8
Total Current Assets NA 933 918 925 916
Net Property & Equipment NA 59 56 58 60
Investments & Advances NA 55 80 86 81
Other Non-Current Assets NA 69 68 71 72
Deferred Charges NA 0 1 1 0
Intangibles NA 22 25 27 27
Deposits & Other Assets NA 0 0 0 1
Total Assets NA 1,140 1,150 1,168 1,160
Liabilities & Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Notes Payable NA 0 0 0 0
Accounts Payable NA 12 5 9 13
Current Portion Long-Term Debt NA 0 0 0 0
Current Portion Capital Leases NA 1 1 1 1
Accrued Expenses NA 28 24 17 14
Income Taxes Payable NA 0 1 0 0
Other Current Liabilities NA 0 0 0 0
Total Current Liabilities NA 41 31 28 29
Mortgages NA 0 0 0 0
Deferred Taxes/Income NA 0 0 1 0
Convertible Debt NA 0 0 0 0
Long-Term Debt NA 0 0 0 0
Non-Current Capital Leases NA 2 2 2 2
Other Non-Current Liabilities NA 1 1 1
Minority Interest (Liabilities) NA 0 0 0 0
Total Liabilities NA 44 33 32 33
Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Preferred Stock NA 0 0 0 0
Common Stock (Par) NA 614 613 613 612
Capital Surplus NA 48 47 45 44
Retained Earnings NA 417 462 463 472
Other Equity NA 17 -5 15 -1
Treasury Stock NA 0 0 0 0
Total Shareholder's Equity NA 1,096 1,117 1,137 1,126
Total Liabilities & Shareholder's Equity NA 1,140 1,150 1,168 1,160
Total Common Equity 0 1,096 1,117 1,137 1,126
Shares Outstanding 381.30 381.30 381.10 381.00 380.80
Book Value Per Share 0.00 2.87 2.93 2.98 2.96